CN115209924A - Rna腺相关病毒（raav）载体及其用途 - Google Patents

Rna腺相关病毒（raav）载体及其用途 Download PDF

Info

Publication number
CN115209924A
CN115209924A CN202280002654.0A CN202280002654A CN115209924A CN 115209924 A CN115209924 A CN 115209924A CN 202280002654 A CN202280002654 A CN 202280002654A CN 115209924 A CN115209924 A CN 115209924A
Authority
CN
China
Prior art keywords
sequence
rna
aav
transcribed
dna
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202280002654.0A
Other languages
English (en)
Chinese (zh)
Inventor
施霖宇
柏伟娅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Huida Gene Therapy Singapore Private Ltd
Huida Shanghai Biotechnology Co ltd
Original Assignee
Huida Shanghai Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huida Shanghai Biotechnology Co ltd filed Critical Huida Shanghai Biotechnology Co ltd
Publication of CN115209924A publication Critical patent/CN115209924A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14123—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/42—Vector systems having a special element relevant for transcription being an intron or intervening sequence for splicing and/or stability of RNA
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/48—Vector systems having a special element relevant for transcription regulating transport or export of RNA, e.g. RRE, PRE, WPRE, CTE
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/50—Vector systems having a special element relevant for transcription regulating RNA stability, not being an intron, e.g. poly A signal

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Mycology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN202280002654.0A 2021-02-07 2022-02-07 Rna腺相关病毒（raav）载体及其用途 Pending CN115209924A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CNPCT/CN2021/075874 2021-02-07
CN2021075874 2021-02-07
PCT/CN2022/075366 WO2022166954A1 (en) 2021-02-07 2022-02-07 Rna adeno-associated virus (raav) vector and uses thereof

Publications (1)

Publication Number Publication Date
CN115209924A true CN115209924A (zh) 2022-10-18

Family

ID=74946911

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202280002654.0A Pending CN115209924A (zh) 2021-02-07 2022-02-07 Rna腺相关病毒（raav）载体及其用途

Country Status (10)

Country Link
US (2) US12031148B2 (https=)
EP (1) EP4288112A4 (https=)
JP (1) JP2024508696A (https=)
KR (1) KR20230142776A (https=)
CN (1) CN115209924A (https=)
AU (1) AU2022217349A1 (https=)
BR (1) BR112023015769A2 (https=)
CA (1) CA3207601A1 (https=)
IL (1) IL305002A (https=)
WO (1) WO2022166954A1 (https=)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116218904A (zh) * 2022-11-03 2023-06-06 国药中生生物技术研究院有限公司 一种可提高工程化细胞外泌体中特定核酸分子载量的方法及其应用
CN117778431A (zh) * 2023-12-04 2024-03-29 广州派真生物技术有限公司 一种用于重组腺相关病毒包装的质粒系统及其应用
WO2024120528A1 (en) * 2022-12-08 2024-06-13 Huidagene Therapeutics (Singapore) Pte. Ltd. Improved system for producing rna-packaged aav particles

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025124549A1 (en) * 2023-12-13 2025-06-19 Huidagene Therapeutics (Singapore) Pte. Ltd. Improved system and method for producing recombinant dna-packaged aav particles
CN117701638B (zh) * 2023-12-18 2024-10-18 苏州新芽基因生物技术有限公司 一种抑制残留aav载体质粒和质粒骨架转录活性的方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109055375A (zh) * 2018-07-26 2018-12-21 东南大学 一种crispr辅助反式增强子激活基因表达的方法及其应用
CN109207477A (zh) * 2015-06-18 2019-01-15 布罗德研究所有限公司 新型crispr酶以及系统
CN110114461A (zh) * 2016-08-17 2019-08-09 博德研究所 新型crispr酶和系统

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346415B1 (en) * 1997-10-21 2002-02-12 Targeted Genetics Corporation Transcriptionally-activated AAV inverted terminal repeats (ITRS) for use with recombinant AAV vectors
JP7044373B2 (ja) * 2015-07-15 2022-03-30 ラトガース，ザ ステート ユニバーシティ オブ ニュージャージー ヌクレアーゼ非依存的な標的化遺伝子編集プラットフォームおよびその用途
WO2018035387A1 (en) * 2016-08-17 2018-02-22 The Broad Institute, Inc. Novel crispr enzymes and systems
EP3565608A4 (en) * 2017-01-05 2020-12-16 Rutgers, The State University of New Jersey TARGETED GENE EDITING PLATFORM INDEPENDENT OF BICATENARY DNA BREAKAGE AND ITS USES
JP7215716B2 (ja) * 2017-01-13 2023-01-31 学校法人自治医科大学 肝臓ゲノム上の凝固関連因子遺伝子を破壊するためのａａｖベクター
BR112019028146A2 (pt) * 2017-07-31 2020-07-07 Sigma-Aldrich Co. Llc rna guia sintético para sistemas ativadores de crispr/cas
CN111349148A (zh) * 2020-03-13 2020-06-30 辉大(上海)生物科技有限公司 一种腺相关病毒载体及其用途
JP2023537296A (ja) * 2020-07-29 2023-08-31 ザ・キャソリック・ユニバーシティ・オブ・アメリカ ヒトゲノムリモデリングのためのバクテリオファージベースの人工ウイルスの設計

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109207477A (zh) * 2015-06-18 2019-01-15 布罗德研究所有限公司 新型crispr酶以及系统
CN110114461A (zh) * 2016-08-17 2019-08-09 博德研究所 新型crispr酶和系统
CN109055375A (zh) * 2018-07-26 2018-12-21 东南大学 一种crispr辅助反式增强子激活基因表达的方法及其应用

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116218904A (zh) * 2022-11-03 2023-06-06 国药中生生物技术研究院有限公司 一种可提高工程化细胞外泌体中特定核酸分子载量的方法及其应用
CN116218904B (zh) * 2022-11-03 2025-04-15 国药中生生物技术研究院有限公司 一种可提高工程化细胞外泌体中特定核酸分子载量的方法及其应用
WO2024120528A1 (en) * 2022-12-08 2024-06-13 Huidagene Therapeutics (Singapore) Pte. Ltd. Improved system for producing rna-packaged aav particles
CN117778431A (zh) * 2023-12-04 2024-03-29 广州派真生物技术有限公司 一种用于重组腺相关病毒包装的质粒系统及其应用

Also Published As

Publication number Publication date
KR20230142776A (ko) 2023-10-11
US12031148B2 (en) 2024-07-09
CA3207601A1 (en) 2022-08-11
EP4288112A4 (en) 2025-08-06
BR112023015769A2 (pt) 2023-12-12
JP2024508696A (ja) 2024-02-28
US20230062529A1 (en) 2023-03-02
US20240368629A1 (en) 2024-11-07
IL305002A (en) 2023-10-01
WO2022166954A1 (en) 2022-08-11
AU2022217349A1 (en) 2023-08-31
EP4288112A1 (en) 2023-12-13

Similar Documents

Publication Publication Date Title
JP7712271B2 (ja) アデノ随伴ウイルスベクター変種
JP7398279B2 (ja) Ｃｒｉｓｐｒ／ｃａｓ９核送達による細胞ｒｎａの狙いを定めた編集
WO2022166954A1 (en) Rna adeno-associated virus (raav) vector and uses thereof
JP2022121364A (ja) 無カプシドａａｖベクター、組成物ならびにベクター製造および遺伝子運搬のための方法
EP3044318B1 (en) Selective recovery
WO2019152816A1 (en) Campaign-ready series of recombinant adeno-associated virus (raav) complementing plasmids
JP2023011736A (ja) 核酸封入ａａｖ中空粒子
JP2024517710A (ja) 蝸牛に形質導入するためのアデノ随伴ウイルスベクター
WO2024120528A1 (en) Improved system for producing rna-packaged aav particles
KR20250031153A (ko) 뇌 심부 구조를 표적화하기 위한 아데노-관련 바이러스 벡터
WO2023184107A1 (en) Crispr-cas13 system for treating mecp2-associated diseases
EP4603585A1 (en) Snrna nucleic acid molecule and application thereof
HK40082840A (en) Rna adeno-associated virus (raav) vector and uses thereof
WO2023147558A2 (en) Crispr methods for correcting bag3 gene mutations in vivo
CN119546751A (zh) 改进的重组腺相关病毒生产方法
US12497617B2 (en) SnRNA targeting USH2A pre-mRNA and application thereof
US20260125704A1 (en) rAAV capsids
Becker Pulling the right viral levers: Engineering, screening and application of next-generation combinatorial AAV vectors
JP2025516715A (ja) 脳微小血管系を標的とするアデノ随伴ウイルスベクター
EP4532720A2 (en) Crispr interference therapeutics for c9orf72 repeat expansion disease
HK40016209A (en) Selective recovery
Becker Inaugural dissertation for obtaining the doctoral degree of the Combined Faculty of Mathematics, Engineering and Natural Sciences

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40082840

Country of ref document: HK

TA01 Transfer of patent application right
TA01 Transfer of patent application right

Effective date of registration: 20231221

Address after: Room 1002, Unit 1, Building 7, No. 160, Basheng Road, Free Trade Experimental Zone, Pudong New Area, Shanghai, March 2012

Applicant after: Huida (Shanghai) Biotechnology Co.,Ltd.

Applicant after: Huida Gene Therapy (Singapore) Private Ltd.

Address before: 200131 Room 1002, Unit 1, Building 7, No. 160 Basheng Road, Free Trade Pilot Zone, Pudong New Area, Shanghai

Applicant before: Huida (Shanghai) Biotechnology Co.,Ltd.